Here are five takeaways:
1. Principal Financial Group sold 154,870 shares as NuVasive’s stock increased 20.99 percent.
2. At the end of the third quarter in 2016, Principal Financial Group had 206,071 NuVasive shares, valued at $13.74 million.
3. NuVasive has a market capitalization of $2.98 billion.
4. Since April 8, 2016, NuVasive shares have increased 21.69 percent.
5. The company has outperformed the S&P500 by 16.04 percent.
More articles on devices:
Medtronic finds its place in orthopedic market with knee-implant service: 5 observations
Pan Medical Corporation announces approval for the InterV Flex and InterV Mico vertebral augmentation systems
Zilretta shows clinical improvement for knee osteoarthritis pain: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
